Research found that vaccinated individuals were 46 per cent less likely to suffer major cardiac events. Doctors explain what ...
After the rofecoxib (Vioxx) withdrawal in 2004 made painfully clear how much harm a passive reporting system can miss, ...
In the latest update to COVID and vaccine-related discourse bubbling up at the FDA, agency officials have recently blocked ...
The studies found serious side effects caused by the COVID and shingles vaccines were rare.
Unpublished COVID-19 and shingles vaccine safety reports have raised fresh debate over transparency in US public health ...
In addition, the Times learned that FDA officials did not allow agency scientists to submit two abstracts for studies on ...
In GSK’s first quarter with Luke Miels as CEO, the company’s flagship shingles vaccine Shingrix set a new quarterly sales ...
In its first set of financial figures since spinning off its consumer health division, GSK has reported a 19% increase in revenues, driven by burgeoning demand for its shingles vaccine Shingrix, which ...
The FDA granted approval to GSK's new shingles vaccine Shingrix on Friday, giving the company the green light on one of its important new products. Analysts at Evalute Pharma puts Shingrix as the most ...
Shingrix, the new shingles vaccine, is over 90 percent effective in preventing the painful viral infection Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results